Bibliografia UJ CM

1/4
P.D. Miller, R.R. Recker, J.-Y. Reginster, B.J. Riss, E[dward] Czerwinski, D. Masanauskaite, A. Kenwright, R. Lorenc, J.A. Stakkestad, P. Lakatos.
Efficacy of monthly oral ibandronate is sustained over 5 years : the MOBILE long-term extension study.
Osteoporosis International
2012 : Vol. 23, nr 6, s. 1747-1756, il., bibliogr. 25 poz., abstr.
p-ISSN: 0937-941X
AZ
ORG
AIF
IF: 4.039
2/4
D. Felsenberg, E[dward] Czerwinski, J. Stakkestad, C. Neate, D. Masanauskaite, J.Y. Reginster.
Efficacy of monthly oral ibandronate is maintained over 5 years : the Mobile LTE study.
Osteoporosis International
2009 : Vol. 20 suppl. 1, s. S 15, abstr. OC 32
Ninth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis ECCEO 9 - IOF, Athens, Greece, 18 - 21 March 2009
SZZ
SIF
3/4
J.J. Stepan, G. Bianchi, E[dward] Czwerinski [Czerwiński], C. Hughes, N. Mairon, D. Masanauskaite, J.A. Stakkestad.
Consistent efficacy with intermittent intravenous ibandronate injections in postmenopausal osteoporosis : DIVA 2-year analysis.
Calcif. Tissue Int.
2006 : Vol. 78 suppl. 1, s. S160, abstr. P470
33rd European Symposium on Calcified Tissues, Prague, Czech Republic, 10-14 May 2006.
SZZ
SIF
4/4
R.R. Recker, L[ouis] G. Ste-Marie, E[dward] Czerwinski, L. Rowell, B. Bonvoisin, D. Masanauskaite, D. Felsenberg.
Intermittent intravenous ibandronate injections have a similar bone safety profile to daily oral dosing.
Calcif. Tissue Int.
2006 : Vol. 78 suppl. 1, s. S156, abstr. P455
33rd European Symposium on Calcified Tissues, Prague, Czech Republic, 10-14 May 2006.
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ